North America is expected to hold dominant position due to increasing research activities and
drug development for Gaucher disease
North America is expected to hold the dominant position in the Gaucher disease treatment market
due to increasing research activities for the development of novel drugs. In 2016, the scientist from
National Institutes of Health researchers collaborated with National Institute of Neurological
Disorders and Stroke (NINDS) and the National Center for Advancing Translational Sciences
(NCATS). Researchers identified a new molecule that shows promising approach for treatment of
the rare Gaucher disease. Europe is expected to be the second largest market for Gaucher disease
treatment due to the initiative taken by European organizations to spread awareness about Gaucher
disease among the population. For instance in 2014, European Gaucher Alliance launched Gaucher
Awareness Day aiming to spread awareness about this rare disease among the European population.
For More Information @ https://www.coherentmarketinsights.com/ongoing-insight/gaucher-
disease-treatment-market-1225
Global Key Players:
Key players operating in global Gaucher disease treatment market include Genzyme Corporation,
Pfizer, Inc., Shire Human Genetics Therapies, Inc., and Actelion Pharmaceuticals Ltd. (acquired by
Johnson & Johnson in June 2017). There are various drugs in pipeline of companies such as Lixte
Biotechnology Holdings Inc, JCR Pharmaceuticals Co Ltd, Pharming Group NV and Orphazyme
ApS, for Gaucher disease treatment.
Gaucher Disease Treatment Market Taxonomy
The Gaucher disease treatment market is segmented on the basis of disease type, treatment type,
and distribution channel.
On the basis of disease type, the Gaucher disease treatment market is segmented into:
•Type 1 Gaucher disease
•Type 2 Gaucher disease
•Type 3 Gaucher disease
On the basis of therapy type, the Gaucher disease treatment market is segmented into:
•Enzyme Replacement Therapy (ERT)
•Substrate Reduction Therapy (SRT)
On the basis of distribution channel, the Gaucher disease treatment market is segmented into:
•Hospitals
•Retail Pharmacies
•Online Pharmacies
Request For Customization @ https://www.coherentmarketinsights.com/insight/request-
customization/1225